Skip to main content

Advertisement

SpringerLink
Log in

Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Stefanovic A, Lossos IS (2009) Extranodal marginal zone lymphoma of the ocular adnexa. Blood 114:501–510

    Article  PubMed  CAS  Google Scholar 

  2. Tanimoto K, Kaneko A, Suzuki S et al (2006) Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma. Ann Oncol 17:135–140

    Article  PubMed  CAS  Google Scholar 

  3. Tanimoto K, Kaneko A, Suzuki S et al (2007) Primary ocular adnexal MALT lymphoma: a long-term follow-up study of 114 patients. Jpn J Clin Oncol 37:337–344

    Article  PubMed  Google Scholar 

  4. Zucca E, Conconi A, Pedrinis E et al (2003) Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 101:2489–2495

    Article  PubMed  CAS  Google Scholar 

  5. Bayraktar S, Stefanovic A, Montague N et al (2010) Central nervous system manifestations of marginal zone B-cell lymphoma. Ann Hematol 89:1003–1009

    Article  PubMed  Google Scholar 

  6. Isaacson PG (1999) Mucosa-associated lymphoid tissue lymphoma. Semin Hematol 36:139–147

    PubMed  CAS  Google Scholar 

  7. Kuo SH, Chen LT, Wu MS et al (2007) Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression. J Pathol 211:296–304

    Article  PubMed  CAS  Google Scholar 

  8. Cheng AL, Yeh KH, Uen WC et al (1998) Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol. Cancer 82:1946–1951

    Article  PubMed  CAS  Google Scholar 

  9. Paik JS, Cho WK, Lee SE et al (2012) Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma. Ann Hematol 91:1393–1401

    Article  PubMed  CAS  Google Scholar 

  10. Du MQ (2007) MALT lymphoma: recent advances in aetiology and molecular genetics. J Clin Exp Hematop 47:31–42

    Article  PubMed  Google Scholar 

  11. Restrepo A, Raez LE, Byrne GE Jr et al (1998) Is central nervous system prophylaxis necessary in ocular adnexal lymphoma? Crit Rev Oncog 9:269–273

    PubMed  CAS  Google Scholar 

  12. Bayraktar S, Bayraktar UD, Stefanovic A et al (2011) Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients. Br J Haematol 152:72–80

    Article  PubMed  Google Scholar 

  13. Antonini G, Cox MC, Montefusco E et al (2007) Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma. J Neurooncol 81:197–199

    Article  PubMed  Google Scholar 

  14. Rubenstein JL, Fridlyand J, Abrey L et al (2007) Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol 25:1350–1356

    Article  PubMed  CAS  Google Scholar 

  15. Batchelor TT, Grossman SA, Mikkelsen T et al (2011) Rituximab monotherapy for patients with recurrent primary CNS lymphoma. Neurology 76:929–930

    Article  PubMed  CAS  Google Scholar 

  16. Tai WM, Chung J, Tang PL et al (2011) Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab. Ann Hematol 90:809–818

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

No financial or other potential conflicts of interest exist for any of the authors.

Author information

Authors and Affiliations

  1. Department of Oncology, Yun-Lin Branch, National Taiwan University Hospital, Yun-Lin, Taiwan

    Huai-Cheng Huang

  2. Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

    Ann-Lii Cheng & Sung-Hsin Kuo

  3. Department of Oncology, National Taiwan University Hospital, No 7, Chung-Shan South Road, Taipei, Taiwan

    Huai-Cheng Huang, Ann-Lii Cheng & Sung-Hsin Kuo

  4. Department of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

    Chung-Wu Lin

  5. Cancer Research Center, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan

    Ann-Lii Cheng & Sung-Hsin Kuo

Authors
  1. Huai-Cheng Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ann-Lii Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chung-Wu Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sung-Hsin Kuo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sung-Hsin Kuo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, HC., Cheng, AL., Lin, CW. et al. Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab. Ann Hematol 92, 989–992 (2013). https://doi.org/10.1007/s00277-012-1651-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1651-7

Keywords

Search

Navigation